Family Management’s BioCardia BCDA Stock Holding History

Family Management’s Portfolio BCDA Stock Details BCDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-5,167	Closed	-$31.5K	–	180
2024 Q1	$31.5K	Hold	5,167	–	–	0.01%	163
2023 Q4	$51.5K	Hold	5,167	–	–	0.01%	151
2023 Q3	$33.3K	Hold	5,167	–	–	0.01%	145
2023 Q2	$207K	Hold	5,167	–	–	0.05%	130
2023 Q1	$151K	Sell	5,167 -4,320	-46%	-$143K	0.03%	128
2022 Q4	$297K	Buy	9,487 +8	+0.1%	+$228	0.07%	108
2022 Q3	$276K	Buy	+9,479	New	+$245K	0.07%	105
2022 Q1	–	Sell	-9,479	Closed	-$276K	–	172
2021 Q4	$276K	Hold	9,479	–	–	0.07%	141
2021 Q3	$446K	Buy	+9,479	New	+$465K	0.12%	113

Other funds holding BCDA

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Pingora Partners Wilson, Wyoming $169M AUM 56.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

GRP

Global Retirement Partners San Rafael, California $5.64B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Family Management's BCDA Position: Q2 2024 in Review

Family Management sold out of BioCardia (BCDA) in Q2 2024, closing a stake of 5,167 shares — an estimated $31.5K sold.

Family Management first reported a position in BCDA in Q3 2021 and held it in 9 quarters. The position peaked at $446K in Q3 2021. 10 funds tracked by Wall St. Rank hold BCDA as of Q2 2024.

Family Management reported no remaining BioCardia position as of Q2 2024 after selling out during the quarter.
Family Management sold 5,167 BioCardia shares in Q2 2024, an estimated $31.5K.
Family Management first reported a position in BioCardia in Q3 2021 and held it in 9 quarters.
Family Management's BioCardia position peaked at $446K in Q3 2021.
10 funds tracked by Wall St. Rank held BioCardia as of Q2 2024.

Based on Family Management's 13F filing for Q2 2024, filed 14 Aug 2024.